Dr Quinlan was appointed to the board on 28 May 2003.Dr Quinlan is a Consultant Physician and a Clinical Professor of Medicine of the University of Western Australia. He is also Professor Foundation Dean of the College of Health and Professor of Medicine of the University of Notre Dame and since 2008 has also been Chancellor of the University.
 

Dr Quinlan holds the position of Chairman of the St John of God Foundation and is a trustee for the St John of God Australia Ltd. He was also a director of the Raine Medical Research Foundation (University of WA) for 21 years and is a director of the Feilman Foundation, the Ear Science Institute of Australia and the Child Health Research Foundation of WA. Dr Quinlan was appointed Chairman on 26 November 2008 and is also a member of the company's Audit Committee.

Dr Quinlan resides in Perth.

Mr. Pellegrino was appointed to the Board as a non executive director on 1 September 2008. Mr Pellegrino was up until October 2009 an executive of Solagran Limited and was responsible for all their international marketing. Mr Pellegrino has operated in public practice for approximately 15 years as an accountant and financial advisor. He is the founder and Director of the Stanford Group of Companies. Charles holds a Batchelor of Arts and a Batchelor of Business in Accounting.

On the 1 November 2009 Mr Pellegrino was appointed executive Managing Director reflecting the need to maximise the investment in Re Gen Wellness Products Pty Ltd. Mr Pellegrino's experience in international marketing, particularly within the Asian region will be essential in securing long term growth for the business.  

Mr Pellegrino resides in Melbourne.

Mr. Langdon was appointed to the Board on 1 September 2008. Mr Langdon brings to the company significant experience in project and risk management within both the Government and private sectors. In the Government sector he has been responsible for the planning, co-ordination and completion of a number of multi-million dollar projects. Most recently, Mr Langdon completed strategic business assessments for various private sector interests in Africa and Australia. He has also been responsible for developing business continuity plans for a number of ASX listed and unlisted companies.

Mr Langdon is also Chairman of the Company's Audit Committee and resides in Melbourne.

Mr. Khouri was appointed to the board on 24 September 2009. Mr Khouri has been in the international finance and equity markets since 1987 through his involvement in various companies listed on the ASX, AIM, TSX, Dow Jones, NASDEQ and the German Exchange. This has enabled him to gain vast experience in the areas of corporate finance, advisory, mergers and acquisitions, capital raisings, joint ventures and farm in negotiations for both listed and unlisted companies in the resource, bio-tech, media and entertainment and telecommunications industries.

Mr Khouri has or still does provide extensive advice to Solagran Limited, Continental Goldfields Limited, Fox Resources Limited, International Goldfields Limited, Nkwe Limited and Boss Energy Limited.

Mr Khouri resides in Lebanon.

 

Executive Management

Mr. May was appointed COO on 27 November 2009. Mr May's career has included stints with CFL, Incitec and Crop Care Australasia where he achieved overseas product registration and market development of a range of pest control products, including the suSCon controlled release formulation technology range of products.

In 2001, he founded his own consulting company Xavca Pty Ltd, where he has helped businesses evaluate new markets and commercialise products. Past clients have included leading agribusiness companies Syngenta, Sorex International, Babolna Bio and AgNova Technologies.

As an active member of the Australian Environmental Pest Managers Association (AEPMA) and is also a graduate member of the Australian Institute of Company Directors., Mr May has established excellent contacts within the pest control industry in addition to the general agribusiness and animal health sectors. His educational qualifications include a Bachelor of Applied Science degree with first class honours from Queensland University and an MBA (majoring in international marketing) from the Queensland University of Technology.

Mr May resides in Brisbane.

Mr. Johnston is a CPA and holds a Diploma in Business Studies for Accountancy and is a graduate member of the Australian Institute of Company Directors. He has 39 years experience with finance and management.
 

Mr. Johnston commenced his career as a trainee Accountant with Orica Pty Ltd (formerly ICI Australia Pty Ltd) in 1971. He had many various roles within Orica including Chief Financial Officer of ICI/Dulux PNG Pty Ltd, Pension Fund Accountant, Engineering Project Accountant and Chief Financial Officer of CropCare Australasia Pty Ltd. In 2000, he left Orica to be Chief Financial Officer and Company Secretary of Griffin Corporation Pty Ltd, a 49% subsidiary of DuPont. In September 2003, DuPont acquired the remaining shareholding of Griffin Corporation and closed their office in Milton, Queensland.
Mr. Johnston is responsible for managing the Company's capital management, fund raising needs and compliance with the Companies Act and ASX Listing Rules as well as internal and external reporting requirements He is also responsible for business development and the contractual arrangements surrounding such initiatives.

Mr Johnston resides in Brisbane.

An integral part of BioProspect's core business is its ability to combine scientific expertise with commercial awareness resulting in directing the company's objectives to further its research and development program towards innovative breakthrough technologies and products.
The company contracts its R&D work out to Australian and international institutions. Some of the Australian organisations are listed as:

• The University of Western Sydney
• Southern Cross University
• Ensis Australia and New Zealand (a JV company with CSIRO)
• Eureka AgResearch
• DeGroot Technical Services